RIZATRIPTAN BENZOATE
- Product NDC
- 70518-2957
- 11-digit product format
- 705182957
- Labeler code
- 70518
- Product ID
- 70518-2957_d7aa814e-5830-a361-e053-2a95a90a4b5e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rizatriptan benzoate
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA204722
- Marketing category
- ANDA
- Marketing start
- 2020-12-04
- Marketing end
- 0000-00-00
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2957-0 | 70518295700 | 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (70518-2957-0) | 2020-12-04 | 0000-00-00 | No | No | Current |